Generic Name: buprenorphine
Brand Name: Sublocade
Manufacturer: Indivior Canada Ltd.
Indications: Opioid use disorder, treatment
Manufacturer Requested Reimbursement Criteria1:
For the treatment of moderate-to-severe opioid use disorder in adults. SUBLOCADE should be used as part of a complete treatment plan that includes counseling and psychosocial support.
Submission Type: New
Project Status: Pending
Call For Patient Input: July 25, 2018
Patient Input Closed: September 14, 2018
Anticipated Date: August 23, 2018
Fee Schedule: Pending
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
mental health, pain management